昭衍新药股东顾晓磊及其一致行动人顾美芳拟清仓式减持公司A股股份

Core Viewpoint - Shareholders Gu Xiaolei and Gu Meifang of Zhaoyan New Drug (603127) plan to conduct a significant reduction of their A-share holdings, which may impact the company's stock performance [1] Group 1: Shareholder Information - Gu Xiaolei currently holds 20.42 million shares, representing approximately 2.73% of the company's total shares [1] - Gu Meifang holds 10.32 million shares, accounting for about 1.38% of the total shares [1] - The total shares to be reduced by both shareholders amount to 30.74 million, which is 4.1% of the company's current total share capital [1] Group 2: Reduction Plan - The reduction plan will commence three trading days after the announcement and will take place over a period of three months [1] - The shares will be sold through centralized bidding on the Shanghai Stock Exchange [1]